TISSUE RENIN-ANGIOTENSIN SYSTEM:A Site of Drug Action?
- 1 April 1997
- journal article
- review article
- Published by Annual Reviews in Annual Review of Pharmacology and Toxicology
- Vol. 37 (1) , 53-69
- https://doi.org/10.1146/annurev.pharmtox.37.1.53
Abstract
▪ Abstract In this review, we present background material that provides partial support for a tissue renin-angiotensin system (RAS). Evidence for the existence of this system relied in part the use of drugs, which has entailed using low doses or concentrations of angiotensin-converting enzyme inhibitors, renin inhibitors, and angiotensin antagonists to block the RAS in vascular beds and in isolated arteries or organs. Other evidence for a tissue RAS has depended upon measurements of the components of the system, i.e. enzymes, substrates, and mRNAs for these proteins. All of these components were first believed to be present in the heart and blood vessels; however, it is now known that renin in the circulating blood derived from the kidney is used for the local synthesis of angiotensins. The main emphasis of the review is on the renal RAS because it is believed that the local RAS is most prominent in this organ. The renal RAS is probably involved in the long- rather than short-term regulation of renal vasc...Keywords
This publication has 69 references indexed in Scilit:
- Converting enzyme inhibition and renal tissue angiotensin II in the rat.Hypertension, 1994
- Effects of Blocking the Angiotensin II Receptor, Converting Enzyme, and Renin Activity on the Renal Hemodynamics of Normotensive Guinea PigsJournal of Cardiovascular Pharmacology, 1993
- Regulation of vascular angiotensin release.Hypertension, 1993
- Local generation and release of angiotensin II in peripheral vascular tissue.Hypertension, 1988
- In vitro renin inhibition to prevent generation of angiotensins during determination of angiotensin I and IILife Sciences, 1988
- Direct release of angiotensins I and II from isolated rat kidney perfused with angiotensinogen-free mediumBiochemical and Biophysical Research Communications, 1987
- Persistent Tissue Converting Enzyme Inhibition Following Chronic Treatment with Hoe498 and MK421 in Spontaneously Hypertensive RatsJournal of Cardiovascular Pharmacology, 1985
- Role of extrarenal and intrarenal converting enzyme inhibition in renal vasodilator response to intravenous captoprilLife Sciences, 1980
- Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation.Hypertension, 1979
- Effects of endogenous renin on the function of the isolated kidneyLife Sciences, 1970